The risk of bipolar disorders in multiple sclerosis

Journal of Affective Disorders

Volumn 155, Issue 1, 2014, Pages 255-260

  Carta, M G ^a   Moro, M F ^a   Lorefice, L ^a,b   Trincas, G ^a   Cocco, E ^a,b   Giudice, E Del ^a   Fenu, G ^a,b   Colom, F ^a,c   Marrosu, M G ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Centro Sclerosi Multipla   (Italy)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar Disorders; Comorbidity; Life time prevalence; MDQ; Mood Disorders; Multiple Sclerosis

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; CYCLOTHYMIA; DSM-IV; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIPLE SCLEROSIS; NULL HYPOTHESIS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; STRUCTURED INTERVIEW;

BIPOLAR DISORDERS; COMORBIDITY; LIFE-TIME PREVALENCE; MDQ; MOOD DISORDERS; MULTIPLE SCLEROSIS;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COMORBIDITY; CYCLOTHYMIC DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; RISK;

EID: 84891863666     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.11.008     Document Type: Article

References (51)

1. J. Angst, T.D. Meyer, R. Adolfsson, P. Skeppar, M. Carta, F. Benazzi, R.B. Lu, Y.H. Wu, H.C. Yang, C.M. Yuan, P. Morselli, P. Brieger, J. Katzmann, I.A. Teixeira Leão, J.A. Del Porto, D. Hupfeld Moreno, R.A. Moreno, O.T. Soares, E. Vieta, and A. Gamma Hypomania: a transcultural perspective World Psychiatry 9 1 2010 41 49
2. A.C. Andreazza, M. Kauer-Sant'Anna, and B.N. Frey et al. Effects of mood stabilizers on DNA damage in an animal model of mania J. Psychiatry Neurosci. 33 2008 516 524
3. A.C. Andreazza, C. Cassini, and A.R. Rosa et al. Serum S100B and antioxidant enzymes in bipolar patients J. Psychiatr. Res. 41 2007 523 529
4. E.A. Bachen, M.A. Chesney, and L.A. Criswell Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus Arthritis Rheum. 61 6 2009 822 829
5. N. Byatt, A.J. Rothschild, P. Riskind, C. Ionete, and A.T. Hunt Relationships between Multiple Sclerosis and Depression J. Neuropsychiatry Clin. Neurosci. 23 2011 198 200
6. R. Bakshi, D. Czarnecki, and S. Zubair et al. Brain MRI lesions are related to depression in multiple sclerosis Brain Imaging 11 2000 1153 1158
7. F. Benazzi Various forms of depression Dialogues Clin. Neurosci. 8 2 2006 151 161
8. R.J. Baldessarini, E. Vieta, J.R. Calabrese, M. Tohen, and C.L. Bowden Bipolar depression: overview and commentary Harv. Rev. Psychiatry 18 3 2010 143 157
9. M.G. Carta, M.C. Hardoy, A. Garofalo, E. Pisano, V. Nonnoi, G. Intilla, G. Serra, C. Balestrieri, L. Chessa, C. Cauli, M.E. Lai, and P. Farci Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy Clin. Pract. Epidemiol. Ment. Health 3 2007 22
10. M.G. Carta, J. Angst, M.F. Moro, G. Mura, M.C. Hardoy, C. Balestrieri, L. Chessa, M.E. Lai, and P. Farci Association of chronic hepatitis C with recurrent brief depression J. Affect. Disord. 141 2-3 2012 361 366 10.1016/j.jad.2012.03.020
11. M.G. Carta, O. Sorbello, M.F. Moro, K.M. Bhat, E. Demelia, A. Serra, G. Mura, F. Sancassiani, M. Piga, and L. Demelia Bipolar disorders and Wilson's disease BMC Psychiatry 12 1 2012 52
12. M.G. Carta, E. Aguglia, M. Balestrieri, J.R. Calabrese, F. Caraci, L. Dell'osso, G. Di Sciascio, F. Drago, C. Faravelli, M.E. Lecca, M.F. Moro, M. Nardini, G. Palumbo, and M.C. Hardoy The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy J. Affect. Disord. 136 3 2012 775 780
13. L. Chwastiak, D.M. Ehde, L.E. Gibbons, M. Sullivan, J.D. Bowen, and G.H. Kraft Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample Am. J. Psychiatry 159 11 2002 1862 1868
14. M.G. Carta, L. Tondo, and M. Balestrieri et al. Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder BMC Psychiatry 11 2011 164 10.1186/1471-244X-11-164
15. M.G. Carta, E. Aguglia, A. Bocchetta, M. Balestrieri, F. Caraci, M. Casacchia, L. Dell'Osso, G. Di Sciascio, F. Drago, C. Faravelli, M.E. Lecca, M.F. Moro, P.L. Morosini, N. Marcello, G. Palumbo, and M.C. Hardoy The use of antidepressant drugs and the lifetimeprevalence of major depressive disorders in Italy Clin. Pract. Epidemiol. Ment. Health 6 2010 94 100
16. M.G. Carta, and J. Angst Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys Clin. Pract. Epidemiol. Ment. Health 1 1 2005 4
17. F. Colom, E. Vieta, C. Daban, I. Pacchiarotti, and J. Sánchez-Moreno Clinical and therapeutic implications of predominant polarity in bipolar disorder J. Affect. Disord. 93 1-3 2006 13 17
18. C. Ewing, and C.C. Bernard Insights into the etiology and pathogenesis of multiple sclerosis Immunol. Cell Biol. 76 1 1998 47 54
19. A. Feinstein An examination of suicidal intent in patients with multiple sclerosis Neurology 59 2002 674 678
20. A. Feinstein, P. Roy, and N. Lobaugh et al. Structural brain abnormalities in multiple sclerosis patients with major depression Neurology 62 2004 586 590
21. M. First, R. Spitzer, M. Gibbon, and J. Williams Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN) 2002 Biometrics Research, New York State Psychiatric Institute New York
22. L. Fajutrao, J. Locklear, J. Priaulx, and A. Heyes A systematic review of the evidence of the burden of bipolar disorder in Europe Clin. Pract. Epidemiol. Ment. Health 5 2009 3
23. A. Feinstein Multiple sclerosis and depression Mult. Scler. 17 2011 1276 1281
24. A. Giordano, F. Granella, A. Lugaresi, V. Martinelli, M. Trojano, P. Confalonieri, D. Radice, and A. Solari SIMS-Trial group. Anxiety and depression in multiple sclerosis patients around diagnosis J. Neurol. Sci. 307 1-2 2011 86 91
25. M.J. Giannini, B. Bergmark, S. Kreshover, E. Elias, C. Plummer, and E. O'Keefe Understanding suicide and disability through three major disabling conditions: intellectual disability, spinal cord injury, and multiple sclerosis Disabil. Health J. 3 2 2010 74 78
26. S.N. Ghaemi, D.J. Hsu, F. Soldani, and F.K. Goodwin Antidepressants in bipolar disorder: the case for caution Bipolar Disord. 5 6 2003 421 433
27. H. Gonzalo, L. Brieva, F. Tatzber, M. Jové, D. Cacabelos, A. Cassanyé, L. Lanau-Angulo, J. Boada, J.C. Serrano, C. González, L. Hernández, S. Peralta, R. Pamplona, and M. Portero-Otin Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism J. Neurochem. 2012 10.1111/j.1471-4159.2012. 07934.x
28. M.C. Hardoy, M. Cadeddu, A. Serra, MF., M. Moro, G. Mura, G. Mellino, K.M. Bhat, G. Altoè, P. Usai, M. Piga, and M.G. Carta A pattern of cerebral perfusion anomalies between Major Depressive Disorder and Hashimoto Thyroiditis BMC Psychiatry 11 2011 148
29. M.C. Hardoy, M.G. Carta, and M. Cadeddu et al. Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders Clin. Pract. Epidemiol. Ment. Health 1 2005 8
30. A. Iacovides, and E. Andreoulakis Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review Curr. Opin. Psychiatry 24 4 2011 336 340
31. R.T. Joffe Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness J. Psychiatry Neurosci. 30 1 2005 9 10
32. R. Khairova, R. Pawar, G. Salvadore, R.T. De Sousa, M.G. Soeiro-De-Souza, M. Salvador, C.A. Zarate, W.F. Gattaz, and R. Machado-Vieira Effects lithium oxidative stress parameters healthy subjects Mol. Med. Rep. 5 3 2012 680 682 10.3892/mmr.2011.732
33. E. Kingwell, J.J. Marriott, and N. Jetté et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review BMC Neurol. 13 2013 128
34. R.C. Kessler, H.S. Akiskal, J. Angst, M. Guyer, M.R.A. Hirschfeld, K.R. Merikangas, and P.E. Stang Validity assess bipolar spectrum disorders WHO CIDI 3.0 J. Affect. Disord. 96 3 2006 259 269
35. C. Konradi, S.E. Sillivan, and H.B. Clay Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis Neurobiol. Dis. 45 1 2012 37 47
36. R. Machado-Vieira, A.C. Andreazza, and C.I. Viale et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects Neurosci. Lett. 421 2007 33 36
37. R. Marrie, R. Horwitz, and G. Cutter et al. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated Mult. Scler. 15 2009 385 392
38. O. Miettinen Confounding and effect - modification Am. J. Epidemiol. 100 1974 350 353
39. B. Müller-Oerlinghausen, and U. Lewitzka Lithium reduces pathological aggression and suicidality: a mini-review Neuropsychobiology 62 1 2010 43 49
40. R. Machado-Vieira, A.C. Andreazza, and C.I. Viale et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects Neurosci. Lett. 421 2007 33 36
41. M.J. Ostacher The evidence for antidepressant use in bipolar depression J. Clin. Psychiatry 67 Suppl. 11 2006 18 21
42. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, M. Filippi, K. Fujihara, E. Havrdova, M. Hutchinson, L. Kappos, F.D. Lublin, X. Montalban, P. O'Connor, M. Sandberg-Wollheim, A.J. Thompson, E. Waubant, B. Weinshenker, and J.S. Wolinsky Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann. Neurol. 69 2 2011 292 302
43. J.J. Rakofsky, and B.W. Dunlop Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review J. Clin. Psychiatry 72 1 2011 81 90
44. P.K. Ranjekar, S.P. Mahadik, and M.V. Hegde et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res. 121 2003 109 122
45. A.D. Sadovnick, R.A. Remick, and J. Allen Depression in multiple sclerosis Neurology 46 1996 628 632
46. R.J. Siegert, and D.A. Abernerhy Depression in multiple sclerosis: a review J Neurol. Neurosurg. Psychiatry 76 2005 469 475
47. V. Salvi, A. Fagiolini, H.A. Swartz, G. Maina, and E. Frank The use of antidepressants in bipolar disorder J. Clin. Psychiatry 69 8 2008 1307 1318
48. M.M. Sidor, and G.M. Macqueen Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis J. Clin. Psychiatry 72 2 2011 156 167
49. L. Shao, L.T. Young, and J.F. Wang Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells Biol. Psychiatry 58 2005 879 884
50. E. Vieta Role of antidepressants in bipolar depression J. Clin. Psychiatry 71 9 2010 e21
51. CA Zarate, J Singh Jr., and HK Manji Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder Biol. Psychiatry 59 2006 1006 1020